FORMA Therapeutics
Jennifer Sweeney is an experienced professional in the field of clinical science and medical management. Currently serving as a Senior International Medical Manager at Novo Nordisk since October 2022, Jennifer has been integral to Forma Therapeutics since November 2016, holding various positions including Senior Director, Director, Associate Director, and Senior Clinical Scientist. Prior experience includes a role as Senior Clinical Scientist at Infinity Pharmaceuticals from 2006 to 2016. Jennifer Sweeney holds a Bachelor of Science degree in Biology from Boston College.
FORMA Therapeutics
Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.